07:52 AM EST, 03/04/2025 (MT Newswires) -- Wave Life Sciences ( WVE ) reported Q4 net income Tuesday of $0.17 per diluted share, swinging from a loss of $0.15 a year earlier.

Two analysts surveyed by FactSet expected a loss of $0.19.

Revenue for the quarter ended Dec. 31 was $83.7 million, up from $29.1 million a year earlier.

Analysts polled by FactSet expected $28.7 million.

The company said that, as of Dec. 31, it had $302.1 million in cash and cash equivalents, likely enough to finance operations into 2027.

Wave Life shares were up 4.2% in recent premarket activity.